Premium
The prognostic implication of the pretreatment nutritional status in diffuse large B ‐cell lymphoma patients treated with rituximab‐based chemotherapy
Author(s) -
Lee J.,
Oh S.,
Lee H.,
Lee W.,
Jo J.,
Shin H.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_68
Subject(s) - medicine , rituximab , hazard ratio , diffuse large b cell lymphoma , vincristine , performance status , confidence interval , cyclophosphamide , gastroenterology , lymphoma , prednisone , retrospective cohort study , international prognostic index , proportional hazards model , b symptoms , oncology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom